Reaktionsgleichung
CCN(C(C)C)C(C)C.[F:10][C:11]1[C:19]([F:20])=[CH:18][CH:17]=[C:16]([F:21])[C:12]=1[C:13]([OH:15])=O.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.[O:44]=[C:45]([N:62]1[CH2:67][CH2:66][NH:65][CH2:64][CH2:63]1)[CH2:46][NH:47][C:48]([C:50]1[CH:55]=[CH:54][C:53]([C:56]2[CH:61]=[CH:60][CH:59]=[CH:58][CH:57]=2)=[CH:52][CH:51]=1)=[O:49]>CN(C=O)C.O>[O:44]=[C:45]([N:62]1[CH2:67][CH2:66][N:65]([C:13](=[O:15])[C:12]2[C:16]([F:21])=[CH:17][CH:18]=[C:19]([F:20])[C:11]=2[F:10])[CH2:64][CH2:63]1)[CH2:46][NH:47][C:48]([C:50]1[CH:51]=[CH:52][C:53]([C:56]2[CH:61]=[CH:60][CH:59]=[CH:58][CH:57]=2)=[CH:54][CH:55]=1)=[O:49]Komponenten
Edukt 5
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
DIPEA (149.8 mg, 1.15 mmol) was added to a stirred solution of 2,3,6-trifluoro-benzoic acid (45.3 mg, 0.26 mmol) in DMF (3 mL), HOBt (38.2 mg, 0.28 mmol) and EDCI.HCl (123.4 mg, 0.64 mmol) at room temperature. After 2 minutes biphenyl-4-carboxylicacid (2-oxo-2-piperazin-1-yl-ethyl)-amide (100 mg, 0.31 mmol) was added and the resulting mixture was stirred at room temperature overnight. Cold water was then added, and the resulting precipitate was filtered. The residue was purified by column chromatography (using 60-120 mesh silica gel and 60% EtOAc in hexane as eluent) to afford 45 mg (36.2% yield) of biphenyl-4-carboxylicacid {2-oxo-2-[4-(2,3,6-trifluoro-benzoyl)-piperazin-1-yl]-ethyl}-amide, LC-MS purity: 92.11%, 1H NMR: (DMSO) δ 7.97-7.9 (d, 2H), 7.74-7.6 (q, 4H), 7.52-7.44 (t, 2H), 7.44-7.36 (m, 1H), 7.36-7.28 (m, 1H), 7.02-6.92 (m, 1H), 4.4-4.26 (dd, 2H), 3.98-3.82 (m, 3H), 3.78-3.72 (t, 1H), 3.68-3.62 (t, 1H), 3.58-3.52 (m, 1H), 3.48-3.38 (m, 2H).
Aufarbeitung
- filtrationthe resulting precipitate was filtered
- customThe residue was purified by column chromatography (using 60-120 mesh silica gel and 60% EtOAc in hexane as eluent)
Quellen und Nachweise
- ORD-Eintrag
- ord-983fe6142fa341278bbdea08969bdbf2
- Quelldatensatz
- uspto-grants-2010_11
- Patentnummer
- US07842696B2
Verknüpfte Notizen
Wird geladen…